Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (181-190 of 334) with videos related to

Pageof 34
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitroStefan Wagner, Christine Hafner, Dorothee Allwardt, et al.
Frontiers in Oncology|September 16, 2022
Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapySjoerd P F T Nota, David O Osei-Hwedieh, David L Drum, et al.
Nuclear Medicine and Biology|January 21, 2017
B7-H3-targeted <sup>212</sup>Pb radioimmunotherapy of ovarian cancer in preclinical modelsBenjamin B Kasten, Rebecca C Arend, Ashwini A Katre, et al.
Clinical Chemistry|February 24, 2009
mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beadsMinoru Kitago, Kazuo Koyanagi, Takeshi Nakamura, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting functionAndrés López-Albaitero, Robbie Mailliard, Trevor Hackman, et al.
European Journal of Immunology|December 10, 2008
Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4Valeria Tosello, Rita Zamarchi, Anna Merlo, et al.
Cancer Research|April 3, 2015
CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor PrognosisHyun-Bae Jie, Patrick J Schuler, Steve C Lee, et al.
Cancer Research|August 4, 2004
Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanomaJames L Murray, Michael Gillogly, Kouichiro Kawano, et al.
The Journal of Cell Biology|June 24, 2004
Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanismsJianbo Yang, Matthew A Price, Cheryl L Neudauer, et al.
Gynecologic Oncology|November 13, 2013
Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96Janelle M Fauci, Francesco Sabbatino, Yangyang Wang, et al.
Pageof 34

Showing results (181-190 of 334) with videos related to

Sort By:
Pageof 34
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitroStefan Wagner, Christine Hafner, Dorothee Allwardt, et al.
Frontiers in Oncology|September 16, 2022
Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapySjoerd P F T Nota, David O Osei-Hwedieh, David L Drum, et al.
Nuclear Medicine and Biology|January 21, 2017
B7-H3-targeted <sup>212</sup>Pb radioimmunotherapy of ovarian cancer in preclinical modelsBenjamin B Kasten, Rebecca C Arend, Ashwini A Katre, et al.
Clinical Chemistry|February 24, 2009
mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beadsMinoru Kitago, Kazuo Koyanagi, Takeshi Nakamura, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross-presenting functionAndrés López-Albaitero, Robbie Mailliard, Trevor Hackman, et al.
European Journal of Immunology|December 10, 2008
Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4Valeria Tosello, Rita Zamarchi, Anna Merlo, et al.
Cancer Research|April 3, 2015
CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor PrognosisHyun-Bae Jie, Patrick J Schuler, Steve C Lee, et al.
Cancer Research|August 4, 2004
Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanomaJames L Murray, Michael Gillogly, Kouichiro Kawano, et al.
The Journal of Cell Biology|June 24, 2004
Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanismsJianbo Yang, Matthew A Price, Cheryl L Neudauer, et al.
Gynecologic Oncology|November 13, 2013
Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96Janelle M Fauci, Francesco Sabbatino, Yangyang Wang, et al.
Pageof 34